BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 3, 2019
Product Development

Kidney is the new liver: why kidney indications are coming into sharp focus

Investors and pharmas see big opportunities in the kidney, based on progress at both ends of the drug development spectrum
BioCentury | Jul 1, 2010
Targets & Mechanisms

PKD: cease and de-cyst

Items per page:
1 - 2 of 2
Help Center
Username
Request a Demo
Request Training
Ask a Question